Literature DB >> 18512957

Crystal structures of substrate-free and retinoic acid-bound cyanobacterial cytochrome P450 CYP120A1.

Karin Kühnel1, Na Ke, Max J Cryle, Stephen G Sligar, Mary A Schuler, Ilme Schlichting.   

Abstract

The crystal structures of substrate-free and all-trans-retinoic acid-bound CYP120A1 from Synechocystis sp. PCC 6803 were determined at 2.4 and 2.1 A resolution, respectively, representing the first structural characterization of a cyanobacterial P450. Features of CYP120A1 not observed in other P450 structures include an aromatic ladder flanking the channel leading to the active site and a triple-glycine motif within SRS5. Using spectroscopic methods, CYP120A1 is shown to bind 13-cis-retinoic acid, 9-cis-retinoic acid, and retinal with high affinity and dissociation constants of less than 1 microM. Metabolism of retinoic acid by CYP120A1 suggests that CYP120A1 hydroxylates a variety of retinoid derivatives in vivo. On the basis of the retinoic acid-bound CYP120A1 crystal structure, we propose that either carbon 2 or the methyl groups (C16 or C17) of the beta-ionone ring are modified by CYP120A1.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18512957     DOI: 10.1021/bi800328s

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  14 in total

Review 1.  Conformational plasticity and structure/function relationships in cytochromes P450.

Authors:  Thomas C Pochapsky; Sophia Kazanis; Marina Dang
Journal:  Antioxid Redox Signal       Date:  2010-10       Impact factor: 8.401

2.  Craniosynostosis and multiple skeletal anomalies in humans and zebrafish result from a defect in the localized degradation of retinoic acid.

Authors:  Kathrin Laue; Hans-Martin Pogoda; Philip B Daniel; Arie van Haeringen; Yasemin Alanay; Simon von Ameln; Martin Rachwalski; Tim Morgan; Mary J Gray; Martijn H Breuning; Gregory M Sawyer; Andrew J Sutherland-Smith; Peter G Nikkels; Christian Kubisch; Wilhelm Bloch; Bernd Wollnik; Matthias Hammerschmidt; Stephen P Robertson
Journal:  Am J Hum Genet       Date:  2011-10-20       Impact factor: 11.025

3.  On the distribution of protein refractive index increments.

Authors:  Huaying Zhao; Patrick H Brown; Peter Schuck
Journal:  Biophys J       Date:  2011-05-04       Impact factor: 4.033

4.  QM/MM refinement and analysis of protein bound retinoic acid.

Authors:  Xue Li; Zheng Fu; Kenneth M Merz
Journal:  J Comput Chem       Date:  2011-11-23       Impact factor: 3.376

Review 5.  Biochemical and physiological importance of the CYP26 retinoic acid hydroxylases.

Authors:  Nina Isoherranen; Guo Zhong
Journal:  Pharmacol Ther       Date:  2019-08-13       Impact factor: 12.310

6.  Substrate specificity and ligand interactions of CYP26A1, the human liver retinoic acid hydroxylase.

Authors:  Jayne E Thatcher; Brian Buttrick; Scott A Shaffer; Jakob A Shimshoni; David R Goodlett; Wendel L Nelson; Nina Isoherranen
Journal:  Mol Pharmacol       Date:  2011-04-26       Impact factor: 4.436

Review 7.  Cytochrome P450s in algae: Bioactive natural product biosynthesis and light-driven bioproduction.

Authors:  Shanmin Zheng; Jiawei Guo; Fangyuan Cheng; Zhengquan Gao; Lei Du; Chunxiao Meng; Shengying Li; Xingwang Zhang
Journal:  Acta Pharm Sin B       Date:  2022-01-24       Impact factor: 14.903

8.  Conformational Analysis of Free and Bound Retinoic Acid.

Authors:  Zheng Fu; Xue Li; Kenneth M Merz
Journal:  J Chem Theory Comput       Date:  2012-02-24       Impact factor: 6.006

9.  Stereoselective formation and metabolism of 4-hydroxy-retinoic Acid enantiomers by cytochrome p450 enzymes.

Authors:  Jakob A Shimshoni; Arthur G Roberts; Michele Scian; Ariel R Topletz; Sean A Blankert; James R Halpert; Wendel L Nelson; Nina Isoherranen
Journal:  J Biol Chem       Date:  2012-10-15       Impact factor: 5.157

10.  CYP26C1 Is a Hydroxylase of Multiple Active Retinoids and Interacts with Cellular Retinoic Acid Binding Proteins.

Authors:  Guo Zhong; David Ortiz; Alex Zelter; Abhinav Nath; Nina Isoherranen
Journal:  Mol Pharmacol       Date:  2018-02-23       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.